At a Glance

Vela Diagnostics facts and figures

Established in 2011
Approximately 200 employees worldwide
Pioneer in offering both real-time PCR and Next-Generation Sequencing on an integrated platform.
More than 30 research or IVD tests in nine disease areas*
15 validated sample types
ISO 13485:2003 certified R&D and manufacturing facilities located in Singapore, with additional R&D facilities in United States
CLIA-certified laboratory in United States
Global network with direct operations and distributors across North America, Europe and Asia Pacific

*regulatory status of products is based on regional availability

2011

Founding of global head office in Singapore, with regional operations set up in New Jersey, US and Hamburg, Germany
Distribution agreement with Qiagen and OEM agreement with Eppendorf
qPCR license with Roche
OEM agreement with Macherey Nagel

2012

Start of direct sales in several European markets including Italy, France, UK, Benelux and Scandinavia
Establishment of qPCR workflows and first CE-IVD tests
OEM agreement with Life Technologies for NGS solutions
CLIA lab license in US
OEM agreement with Swift Biosciences

2013

Start of direct sales in Australia and Malaysia
Distribution agreement with AmeriLab for China and Diagnostica Longwood for Spain

2014

Start of direct sales in Thailand
NGS license agreement with Appistry
Launch of the first NGS-based oncology panel for IVD use in Europe and parts of Asia
Distribution agreement with SurgiTech AS for Estonia

2015